ArticleNeurology and therapy2026

Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.

Pavel Šiarnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.